Despite empirical evidence affirming elevated circulating interleukin-17 (IL-17) levels and increased Th17 lymphocyte counts in vitiligo patients, along with heightened expression levels of IL-17A messenger RNA in vitiligo lesions [77], the precise role of IL-17 remains elusive. The gene discussed is IL17A; the disease is vitiligo.